Cargando…

The quantifying relationship between the remission duration and the cardiovascular and kidney outcomes in the patients with primary nephrotic syndrome

BACKGROUND: Patients with persistent nephrotic-range proteinuria have a high risk of kidney dysfunction and cardiovascular events. Recently, the maintenance of proteinuria remission has been demonstrated to reduce the risk of kidney endpoint. However, the effect of remission duration on cardiovascul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Xuan, Cui, Zhao, Zhang, Hua, Zhang, Yi-miao, Wang, Fang, Wang, Xin, Meng, Li-qiang, Cheng, Xu-yang, Liu, Gang, Zhao, Ming-hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662000/ https://www.ncbi.nlm.nih.gov/pubmed/36369936 http://dx.doi.org/10.1080/0886022X.2022.2143377

Ejemplares similares

Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis
por: Jauhal, Arenn, et al.
Publicado: (2022)

Low-dose cyclosporine in treatment of membranous nephropathy with nephrotic syndrome: effectiveness and renal safety
por: Yu, Xiaojuan, et al.
Publicado: (2017)

Initial steroid regimen in idiopathic nephrotic syndrome can be shortened based on duration to first remission
por: Baek, Hee Sun, et al.
Publicado: (2015)

Acute kidney injury in idiopathic membranous nephropathy with nephrotic syndrome
por: Chen, Tianxin, et al.
Publicado: (2021)

Low molecular weight heparin may benefit nephrotic remission in steroid-sensitive nephrotic syndrome via inhibiting elastase
por: Zhai, Songhui, et al.
Publicado: (2017)

Serum free fatty acid elevation is related to acute kidney injury in primary nephrotic syndrome
por: Zhang, Lili, et al.
Publicado: (2022)

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome
por: Dorresteijn, Eiske M., et al.
Publicado: (2008)

Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS)
por: Yamamoto, Ryohei, et al.
Publicado: (2020)

Rituximab shows no effect on remission in patients with refractory nephrotic syndrome: A MOOSE-compliant meta-analysis
por: Yin, Supei, et al.
Publicado: (2016)

Complete remission of nephrotic syndrome and acute kidney injury in crescentic IgA nephropathy: Role of mycophenolate sodium
por: Bhandari, D., et al.
Publicado: (2016)

Nephrotic Syndrome and Idiopathic Membranous Nephropathy Associated with Autosomal-Dominant Polycystic Kidney Disease
por: Peces, Ramón, et al.
Publicado: (2011)

Cardiovascular outcomes of Nephrotic syndrome in childhood (CVONS) study: a protocol for prospective cohort study
por: Patnaik, S. K., et al.
Publicado: (2018)

Acute kidney injury in idiopathic nephrotic syndrome of childhood is a major risk factor for the development of chronic kidney disease
por: Yaseen, Afshan, et al.
Publicado: (2017)

DNA methylation changes between relapse and remission of minimal change nephrotic syndrome
por: Kobayashi, Yasuko, et al.
Publicado: (2012)

Regulatory and effector T cells changes in remission and resistant state of childhood nephrotic syndrome
por: Jaiswal, A., et al.
Publicado: (2014)

Remission of nephrotic syndrome in amyloidosis of familial Mediterranean fever following colchicine treatment
por: Odabas, Hatice
Publicado: (2006)

Spontaneous remission in a child with an NPHS1-based congenital nephrotic syndrome
por: Espinosa, Laura García, et al.
Publicado: (2022)

Comparison between outcomes of IgA nephropathy with nephrotic-range proteinuria and nephrotic syndrome: do podocytes play a role?
por: Chen, Yizhen, et al.
Publicado: (2022)

Relationship between Maternal Postpartum Intention to Breastfeed and Actual Breastfeeding Duration — Four Provinces, China, 2015–2017
por: Zhang, Chunying, et al.
Publicado: (2022)

Study on the relationship between nephrotic syndrome and atopic diseases in childhood
por: Zheng, Yue, et al.
Publicado: (2022)

Effects of statin therapy and treatment duration on cardiovascular disease risk in patients with nephrotic syndrome: A nested case–control study
por: Zou, Xinliang, et al.
Publicado: (2022)

Efficacy of Mycophenolate Mofetil as a Remission Maintaining Agent in Idiopathic Childhood Nephrotic Syndrome
por: Nandi, M., et al.
Publicado: (2019)

Persistent Abnormalities of Fatty Acids Profile in Children With Idiopathic Nephrotic Syndrome in Stable Remission
por: Turolo, Stefano, et al.
Publicado: (2021)

Effect of kidney disease on all-cause and cardiovascular mortality in patients undergoing coronary angiography
por: Li, Qiang, et al.
Publicado: (2023)

Acute Kidney Injury in Nephrotic Syndrome
por: Menon, Shina
Publicado: (2019)

Quantifying Remission Probability in Type 2 Diabetes Mellitus
por: Kalra, Sanjay, et al.
Publicado: (2021)

The rationale and design of Insight into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics (INSIGHT): a prospective cohort study of childhood nephrotic syndrome
por: Hussain, Neesha, et al.
Publicado: (2013)

Optimal timing of coronary angiograms for patients with chronic kidney disease: association between the duration of kidney dysfunction and SYNTAX scores
por: Song, Bei, et al.
Publicado: (2021)

Plasmapheresis leading to remission of refractory nephrotic syndrome due to fibrillary glomerulonephritis: a case report
por: Pliquett, Rainer U, et al.
Publicado: (2012)

Minimal Change Nephrotic Syndrome Relapse after 52 Years of Remission: A Case Report
por: Yamabe, Hideaki, et al.
Publicado: (2018)

Assessment of Behavior Abnormalities of Corticosteroids in Children with Nephrotic Syndrome
por: Youssef, Doaa Mohammed, et al.
Publicado: (2013)

Fecal microbiota transplantation induces remission of infantile allergic colitis through gut microbiota re-establishment
por: Liu, Sheng-Xuan, et al.
Publicado: (2017)

The Role of Glucocorticoid Receptors in Podocytes and Nephrotic Syndrome
por: Zhao, Xuan, et al.
Publicado: (2018)

HIGH LONG-TERM DRUG-FREE REMISSION RATE FOR ACUTE VOGT–KOYANAGI–HARADA DISEASE WITH AN APPROPRIATE IMMUNOSUPPRESSIVE REGIMEN
por: Wang, Kaixuan, et al.
Publicado: (2023)

Comparison of the prophylactic antithrombotic effect of indobufen and warfarin in patients with nephrotic syndrome: a randomized controlled trial
por: Gao, Xin-Yi, et al.
Publicado: (2023)

Tripterygium glycosides improve abnormal lipid deposition in nephrotic syndrome rat models
por: Zheng, Bidan, et al.
Publicado: (2023)

Exploiting antitumor immunity to overcome relapse and improve remission duration
por: Chen, Lei L., et al.
Publicado: (2011)

Treatment of Steroid and Cyclosporine-Resistant Idiopathic Nephrotic Syndrome in Children
por: Nikibakhsh, A. A., et al.
Publicado: (2011)

Duration of initial prednisolone therapy for first episode of childhood nephrotic syndrome based on time to response
por: Tang, Xiaoshan, et al.
Publicado: (2022)

Glomerulosclerosis is a prognostic risk factor in patients with membranous nephropathy and non-nephrotic proteinuria
por: Sun, Jing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vqcfonr6538vqipbhpq4o5710k